BTK and neoplasm: Moreover, the activation of Bruton’s tyrosine kinase (BTK) in TIL-Bs has been found to drive the reprogramming of tumor-infiltrating macrophages to the M2 phenotype, impairing CD8+ T-cell-mediated antitumor responses, and contributing to the progression of PDAC [298,299].